Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Giga Metals to Present at the Battery & Precious Metals Virtual Investor Conference July 23rd, 2024
-
KIC Realty Introduces Comprehensive Health Benefits for Staff and Their Families
-
FREEBIRDS CERTIFIED AS A “GREAT PLACE TO WORK”
-
Katherine Lauderdale Appointed to Professional Diversity Network, Inc.’s Board of Directors
-
Form 8.3 - Keywords Studios Plc
-
Rakovina Therapeutics Announces Second Upsizing of Private Placement
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
LAKE (LAK3) Announces Strategic Partnership with Premier League Club Wolverhampton Wanderers FC
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
OnEquity Unveils New Website: CFD & FX Trading for Global Markets
-
OnEquity Unveils New Website: CFD & FX Trading for Global Markets
-
WEEX Token (WXT) White Paper Launch: Unveiling a High-Growth Utility Token
-
Significant Donation Helped USO Expand Its Impact in Europe
-
Fintech360 Unveils Financial Technology Solutions Based on AWS Cloud for Brokers
-
INNOVATE Corp. Announces 1-for-10 Reverse Stock Split of the Company’s Common Stock
-
Sify Q1 Earnings Call deferred due to outage on vendor platform
-
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
-
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
-
Acme United Reports 29% Increase in Net Income for Second Quarter of 2024
-
Linklogis Selected for S&P Global’s Sustainability Yearbook 2024 (China Edition)
-
WholisticResearch Announces Launch of AI-Based Nootropics Research Assistant NootsAI™
-
Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Rep
-
Endeavor Bancorp Reports Pretax Income of $1.1 million for the Second Quarter of 2024; Results Highlighted by Substantial Loan Growth and Net Interest Margin Expansion
-
Omnium Brewing Opening New Taproom in Nashua, NH This Summer
-
Grayscale Investments® Announces Record Date and Distribution Date for Grayscale Bitcoin Trust (Ticker: GBTC) Shareholders
-
Linklogis Selected for S&P Global’s Sustainability Yearbook 2024 (China Edition)
-
eXp Realty Names Troy Palmquist Vice President of Growth and Product Marketing
-
Nokia accelerates its share buybacks
-
Oversee Combines Conversational AI with Automation; Launches “AgentAI” to Drive TMC Operational Efficiency and Improved Traveler Experience
-
UPDATE -- Logansport Financial Corp. Reports Net Earnings for the Quarter Ended June 30, 2024
-
PrimoHoagies Voted #1 Sandwich Shop in America for Two Consecutive Years
-
Occidental Announces Commencement of Exchange Offer and Consent Solicitation for CrownRock Notes
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Alliance Trust PLC - Net Asset Value
-
Yara International ASA - Mandatory notification of trade
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
AITX Announces Significantly Improved Equity Financing Agreement
-
Star Equity Holdings Announces Closing of Two Sale-Leaseback Transactions
-
Drilling Commences at Arau Project, Papua New Guinea
-
Mount Logan Capital Inc. Schedules Release of Second Quarter 2024 Results
-
Clarus Sets Second Quarter 2024 Conference Call for Thursday, August 1, 2024, at 5:00 p.m. ET
-
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
-
NANO Nuclear Energy Closes Full Over-Allotment Option Raising Total Funds of $20 Million in Underwritten Follow-On Offering
-
BCB Bancorp, Inc. Earns $2.8 Million in Second Quarter 2024; Reports $0.14 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share
-
Reliance Global Group Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
-
Statkraft AS: Release of second quarter results 2024
-
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
-
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
-
Sify (NASDAQ: SIFY) reports Consolidated Financial Results for Q1 FY 2024-25
-
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
